Formulations Mydriatic 3 (Tropi-Cyclo-Phenyl)* – 1mL

Mydriatic 3 (Tropi-Cyclo-Phenyl)* – 1mL


Not available from our FDA registered outsourcing facility. Available from our patient specific pharmacy.

Click here to download the product insert for this formulation.

Shipped cold overnight and needs refrigeration.

Classification Topical Medication
Sub-classification Solution
Strength (Concentration) common dose* 1/1/2.5%
Size (Volume) 1mL Dropper

Order today from our FDA-Registered Outsourcing Facility

Order your prescriptions now.

Order Now

*For professional use only. ImprimisRx® Pharmacy specializes in customizing medications to meet unique patient and practitioner needs. ImprimisRx® dispenses only to individually identified patients with valid prescriptions. No compounded medication is reviewed by the FDA for safety or efficacy. ImprimisRx® does not compound copies of commercially available products. References available upon request.

Potential Ingredient Risks

Storage: Store under refrigeration: 2°C to 8°C (36°F to 46°F)

Auxiliary Labeling: Store upright in original bottle, Protect from light. For professional use only.


Possible Indications: Cycloplegia, Mydriasis

Possible Adverse Effects: Blurred Vision, Cardiorespiratory Arrest, Headache, Hypersensitivity Reaction,
Increased Intraocular Pressure, Muscle Rigidity, Nausea, Pallor, Photophobia, Psychotic Reaction, Superficial Punctate Keratitis, Tachycardia, Transient Burning or Stinging in the Eyes, Vomiting, Xerostomia

Potential Contraindications/Precautions: Patients less than 12 years of age. Lactation. Pregnancy.


Possible Indications: Cycloplegia, Mydriasis, Posterior Synechiae, Uveitis

Possible Adverse Effects: Blurred Vision, Burning Sensation, Coma, Death, Disorientation, Dry Secretions,
Eye Irritation, Hallucination, Hyperactive Behavior, Hyperpyrexia, Hypertension, Hyperhidrosis, Increased Intraocular Pressure, Photophobia, Psychotic Reaction, Restlessness, Seizure, Superficial Punctate Keratitis, Tachycardia, Urinary Retention, Vasodilation, Xerostomia

Potential Contraindications/Precautions: Infants

Phenylephrine HCl

Possible Indications: Mydriasis, Posteriro Synechiae, Uveitis with Posterior Synechiae

Possible Adverse Effects: Acute Keratitis, Acute Myocardial Infarction, Allergic Conjunctivitis, Blurred Vision,
Dermatitis, Diaphoresis, Dizziness, Eye Irritation, Headache, Hypertension, Lacrimation, Pallor, Photophobia,
Pigment Granules Liberation from the Iris, Subarachnoid Hemorrhage, Syncope, Tachycardia, Tremor, Ventricular Premature contractions

Potential Contraindications/Precautions: Neonates and patients less than 12 years of age. Lactation. Pregnancy.